| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |